Frank Corrigan, MD
Interventional Cardiology · Atlanta, GANPI 1932348885
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Heartflow, Inc. at 57.7% of the total. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 555 payments — averaging $180.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heartflow, Inc.$58K
- Novartis$16K
- Boston Scientific$11K
- Abbott$4K
- Edwards Lifesciences$4K
- Medtronic$3K
- plus $4K from 28 others
Across 4 payments — averaging $40,381 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$145K
- Boston Scientific$15K
- Medtronic$1K
What the payments were for
- Consulting fees$27,01327%
- Speaking & faculty fees$42,67343%
- Travel & lodging$13,29813%
- Food & beverage$16,91217%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heartflow, Inc. | 65 | $57,614 |
| Novartis | 29 | $16,157 |
| Boston Scientific | 180 | $11,018 |
| Abbott | 80 | $4,073 |
| Edwards Lifesciences | 27 | $3,796 |
| Medtronic(2 entities) | 38 | $3,109 |
| Shockwave Medical, Inc | 22 | $875 |
| Amgen | 20 | $599 |
| Inari Medical, Inc. | 6 | $546 |
| Abiomed | 3 | $308 |
| Siemens Medical Solutions USA, Inc. | 2 | $175 |
| Boehringer Ingelheim | 10 | $170 |
| Merck | 10 | $168 |
| Novo Nordisk | 7 | $145 |
| E.r. Squibb & Sons, L.L.C. | 9 | $142 |
| Johnson & Johnson | 9 | $128 |
| W. L. Gore & Associates, Inc. | 3 | $94 |
| Pfizer | 5 | $91 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $85 |
| Imperative Care, Inc | 3 | $82 |
| Stryker | 1 | $79 |
| Penumbra, Inc. | 3 | $71 |
| AstraZeneca | 3 | $61 |
| Recor Medical Inc | 2 | $55 |
| Philips North America LLC | 1 | $53 |
| Bayer | 2 | $43 |
| Vital Connect, Inc | 1 | $32 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $28 |
| Bridgebio Pharma, Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Cordis US CORP. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$57,045
- LEQVIO$15,625
- Watchman$5,949
- CoreValve Evolut$1,813
- EVOQUE$1,220
- Tendyne Mitral Valve System$921
- NeuroBlate Robotic Probe Driver$593
- MitraClip$512
- FLOWTRIEVER CATHETER, S$372
- CT THROMBECTOMY SYSTEM KIT$372
- Impella$294
- PASCAL$255
- WATCHMAN Access System$243
- Resolute$200
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$184
- SYMPLICITY G3$163
- SAPIEN 3 Ultra RESILIA$150
- Repatha$149
- WATCHMAN FLX$149
- COREVALVE EVOLUT R$147
How this compares
$99,915 in reported general payments places this provider in the 90th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 217 | $220,593 |
| JardianceEmpagliflozin | 161 | $189,240 |
| XareltoRivaroxaban | 45 | $60,281 |
| OzempicSemaglutide | 58 | $57,760 |
| FarxigaDapagliflozin Propanediol | 48 | $49,460 |
| EntrestoSacubitril/Valsartan | 37 | $45,709 |
| MounjaroTirzepatide | 29 | $27,521 |
| Repatha SureclickEvolocumab | 38 | $25,168 |
| Atorvastatin Calcium | 336 | $3,420 |
| Metoprolol Succinate | 263 | $3,132 |
| Ezetimibe | 97 | $2,563 |
| Rosuvastatin Calcium | 200 | $2,185 |
| Carvedilol | 152 | $1,273 |
| Prasugrel Hcl | 13 | $1,227 |
| Ranolazine ErRanolazine | 19 | $982 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $91 | $220,593217 claims |
| Boehringer IngelheimJardiance | $170 | $189,240161 claims |
| Johnson & JohnsonXarelto | $128 | $60,28145 claims |
| Novo NordiskOzempic | $145 | $57,76058 claims |
| AstraZenecaFarxiga | $61 | $49,46048 claims |
| NovartisEntresto | $16,157 | $45,70937 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 218 interventional cardiology providers in Georgia.
Other interventional cardiology in Atlanta
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Adam GreenbaumAtlanta$238K
- Wissam JaberAtlanta$222K
- Katherine KunkelAtlanta$189K
- James StewartAtlanta$174K
- Pratik SandesaraAtlanta$165K
- Chandanreddy DevireddyAtlanta$121K
- Prashant KaulAtlanta$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.